Mutares Navigates Debt Constraints and Portfolio Overhaul with SABIC and Relobus Deals
16.05.2026 - 12:54:39 | boerse-global.de
The gap between operational progress and market perception continues to widen at Mutares. The Munich-based turnaround specialist delivered a 10% revenue increase in the first quarter to €1.68 billion, swung adjusted EBITDA positive, and completed a significant portfolio exit — yet the stock remains under pressure, trading more than 11% lower year-to-date at €26.45.
The sale of portfolio company Relobus to Infracapital on May 12 marks the latest validation of the buy-fix-sell model. Such transactions are central to Mutares' value creation strategy, turning around underperforming assets and then realising gains. With an exit pipeline that management describes as the largest in the company's history, further divestments are expected in the coming months, particularly in defence, energy and energy infrastructure.
That pipeline includes Efacec, where Mutares forecasts 2026 EBITDA between €40 million and €50 million and sees a natural candidate for a high-value sale. The company's order book stands at roughly €1.5 billion, with a target EBITDA margin of around 20% by 2027. Meanwhile, NEM Energy has already booked over €500 million in new orders in the first months of 2026.
The biggest strategic shift, however, lies in the planned acquisition of SABIC’s Engineering Thermoplastics business in the Americas and Europe. The deal, signed in January, is expected to close in the second quarter of 2026. With roughly €2.0 billion in both revenue and equity, it would be Mutares' largest-ever acquisition and forms the cornerstone of a new "Chemicals & Materials" segment. The goal is to build an integrated platform for specialty chemicals, materials and intermediates, leveraging scale and cross-selling across portfolio companies.
Should investors sell immediately? Or is it worth buying Mutares?
The operational numbers support the narrative of a business gaining traction. Consolidated revenue rose to €1,678.7 million in the first quarter, and adjusted EBITDA turned positive at €11.1 million after a negative figure in the year-earlier period. The holding level remained slightly in the red, but the comparison is distorted by a partial exit of Steyr Motors that boosted prior-year results.
The bond market remains a more sensitive topic. Mutares breached a financial covenant late last year after valuation effects and higher lease liabilities weighed on the relevant metric. Creditors granted a waiver, avoiding immediate acceleration. Now the company has launched a buyback offer for up to €25 million of its variable-rate 2023/2027 note, which has a total principal amount of €250 million, at 101% of par plus accrued interest. Management aims to reduce net debt to between €250 million and €300 million by the end of 2026, making deleveraging a parallel priority alongside portfolio exits.
Insider buying in late April at prices around €24.50 signals confidence from leadership. Several executives purchased shares during the weakness, reinforcing faith in the long-term strategy. Analysts are also bullish: the average price target stands at €41.50, with Warburg Research and Jefferies both maintaining buy recommendations. At a market capitalisation of roughly €672 million, the stock screens as defensive relative to the underlying earnings momentum.
Mutares at a turning point? This analysis reveals what investors need to know now.
Technically, the shares remain well below their 200-day moving average of €29.14, a gap of over 9%. The 52-week high of nearly €37 looks distant. A dividend proposal of €2.00 per share, to be voted on at the annual general meeting on July 3, 2026, offers a modest yield but does little to offset the year-to-date decline.
For the second quarter, three milestones will determine investor sentiment: closing the SABIC deal, making tangible progress on bond buybacks, and executing concrete exits from the pipeline. Mutares is presenting a cleaner portfolio structure, but the market wants proof that the new architecture delivers more than just a reshuffled deck.
Ad
Mutares Stock: New Analysis - 16 May
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Mutares Aktien ein!
Für. Immer. Kostenlos.
